Hangzhou Tigermed Consulting Co (FRA:5HZ1) Total Liabilities : €615.2 Mil (As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Hangzhou Tigermed Consulting Co Total Liabilities?

Hangzhou Tigermed Consulting Co's Total Liabilities for the quarter that ended in Mar. 2025 was €615.2 Mil.

Hangzhou Tigermed Consulting Co's quarterly Total Liabilities declined from Sep. 2024 (€745.88 Mil) to Dec. 2024 (€604.23 Mil) but then increased from Dec. 2024 (€604.23 Mil) to Mar. 2025 (€615.15 Mil).

Hangzhou Tigermed Consulting Co's annual Total Liabilities increased from Dec. 2022 (€645.27 Mil) to Dec. 2023 (€671.32 Mil) but then declined from Dec. 2023 (€671.32 Mil) to Dec. 2024 (€604.23 Mil).

Hangzhou Tigermed Consulting Co Total Liabilities Historical Data

The historical data trend for Hangzhou Tigermed Consulting Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Tigermed Consulting Co Total Liabilities Chart

Hangzhou Tigermed Consulting Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

207.10

435.74

645.27

671.32

604.23

Hangzhou Tigermed Consulting Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															707.35	813.10	745.88	604.23	615.15

Hangzhou Tigermed Consulting Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hangzhou Tigermed Consulting Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	480.32	+	(94.831	+	28.717
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.365)
	=	604.2

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	3760.74	-	3156.507
	=	604.2

Hangzhou Tigermed Consulting Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	463.913	+	(123.109	+	27.779
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0.365)
	=	615.2

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	3665.854	-	3050.703
	=	615.2

Hangzhou Tigermed Consulting Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hangzhou Tigermed Consulting Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Tigermed Consulting Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Hangzhou Tigermed Consulting Co Ltd (FRA:5HZ1) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

03347:Hong Kong 300347:China

Address

Block 8, No. 19 Jugong Road, Room 2001-2010, 20th Floor, Xixing Sub-District, Binjiang District, Hangzhou, CHN, 310053

Website

https://www.tigermed.net

Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. The company's segment includes Clinical trial solutions and Clinical-related and laboratory services. It generates maximum revenue from the Clinical trial solutions segment. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.

Hangzhou Tigermed Consulting Co Headlines

No Headlines